Basma Adeem Medical company (TADAWUL:9626)

TADAWUL:9626 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	8.12	5.16
Cash & Short-Term Investments	8.12	5.16
Cash Growth	57.42%	-
Accounts Receivable	-	0.26
Other Receivables	0.51	0.18
Receivables	0.51	0.43
Inventory	0.6	0.12
Prepaid Expenses	0.48	0.09
Other Current Assets	0.05	0.06
Total Current Assets	9.75	5.86
Property, Plant & Equipment	7.17	7.23
Other Intangible Assets	0.04	0
Total Assets	16.96	13.09
Accounts Payable	1.17	1.6
Accrued Expenses	1.19	1.12
Current Portion of Leases	0.95	0.23
Current Income Taxes Payable	0.19	0.1
Other Current Liabilities	0.04	0.04
Total Current Liabilities	3.53	3.08
Long-Term Leases	3.43	4.89
Total Liabilities	7.16	8.15
Common Stock	0.1	0.05
Additional Paid-In Capital	1.14	1.19
Retained Earnings	8.56	3.7
Shareholders' Equity	9.8	4.94
Total Liabilities & Equity	16.96	13.09
Total Debt	4.37	5.12
Net Cash (Debt)	3.75	0.04
Net Cash Growth	9671.36%	-
Filing Date Shares Outstanding	18.4	-
Working Capital	6.22	2.78
Tangible Book Value	9.77	4.94
Machinery	3.42	2.79
Leasehold Improvements	1.94	1.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.